|Severe hypoglycemia and risks of vascular events and death|
S Zoungas, A Patel, J Chalmers, BE De Galan, Q Li, L Billot, M Woodward, ...
New England Journal of Medicine 363 (15), 1410-1418, 2010
|Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects|
Y Ben-Shlomo, M Spears, C Boustred, M May, SG Anderson, EJ Benjamin, ...
Journal of the American College of Cardiology 63 (7), 636-646, 2014
|Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes|
T Ninomiya, V Perkovic, BE De Galan, S Zoungas, A Pillai, M Jardine, ...
Journal of the American Society of Nephrology 20 (8), 1813-1821, 2009
|Follow-up of blood-pressure lowering and glucose control in type 2 diabetes|
S Zoungas, J Chalmers, B Neal, L Billot, Q Li, Y Hirakawa, H Arima, ...
New England Journal of Medicine 371 (15), 1392-1406, 2014
|Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials|
HJL Heerspink, T Ninomiya, S Zoungas, D de Zeeuw, DE Grobbee, ...
The Lancet 373 (9668), 1009-1015, 2009
|Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the …|
International Hypoglycaemia Study Group
Diabetes care 40 (1), 155-157, 2017
|Diabetes and hypertension: a position statement by the American Diabetes Association|
IH De Boer, S Bangalore, A Benetos, AM Davis, ED Michos, P Muntner, ...
Diabetes care 40 (9), 1273-1284, 2017
|Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: new results from …|
S Zoungas, BE De Galan, T Ninomiya, D Grobbee, P Hamet, S Heller, ...
Diabetes care 32 (11), 2068-2074, 2009
|Association of HbA 1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds|
S Zoungas, J Chalmers, T Ninomiya, Q Li, ME Cooper, S Colagiuri, ...
Diabetologia 55 (3), 636-643, 2012
|Intensive glucose control improves kidney outcomes in patients with type 2 diabetes|
V Perkovic, HL Heerspink, J Chalmers, M Woodward, M Jun, Q Li, ...
Kidney international 83 (3), 517-523, 2013
|Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes|
S Zoungas, M Woodward, Q Li, ME Cooper, P Hamet, S Harrap, S Heller, ...
Diabetologia 57 (12), 2465-2474, 2014
|Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial|
S Zoungas, BP McGrath, P Branley, PG Kerr, C Muske, R Wolfe, ...
Journal of the American College of Cardiology 47 (6), 1108-1116, 2006
|Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial|
Y Hirakawa, H Arima, S Zoungas, T Ninomiya, M Cooper, P Hamet, ...
Diabetes care 37 (8), 2359-2365, 2014
|Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials|
S Zoungas, H Arima, HC Gerstein, RR Holman, M Woodward, P Reaven, ...
The lancet Diabetes & endocrinology 5 (6), 431-437, 2017
|Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy|
S Zoungas, T Ninomiya, R Huxley, A Cass, M Jardine, M Gallagher, ...
Annals of internal medicine 151 (9), 631-638, 2009
|Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron …|
BE De Galan, S Zoungas, J Chalmers, C Anderson, C Dufouil, A Pillai, ...
Diabetologia 52 (11), 2328-2336, 2009
|Diabetic kidney disease|
MC Thomas, M Brownlee, K Susztak, K Sharma, KAM Jandeleit-Dahm, ...
Nature reviews Disease primers 1 (1), 1-20, 2015
|Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis|
SC Palmer, L Di Micco, M Razavian, JC Craig, V Perkovic, F Pellegrini, ...
Annals of internal medicine 156 (6), 445-459, 2012
|Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial|
MJ Jardine, T Ninomiya, V Perkovic, A Cass, F Turnbull, MP Gallagher, ...
Journal of the American College of Cardiology 56 (12), 956-965, 2010
|Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial|
J Hata, H Arima, PM Rothwell, M Woodward, S Zoungas, C Anderson, ...
Circulation 128 (12), 1325-1334, 2013